← Leaderboards
Marilyn J Telen
Duke University
$25,715,109
Attributed
$26,907,413
Total exposure
14
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$34,796,689 · 14
FDA$469,877 · 1
By mechanism
R01$13,671,661 · 6
U54$8,359,153 · 1
T32$7,321,109 · 1
K12$3,985,060 · 1
R21$1,596,947 · 4
U10$303,469 · 1
Top collaborators
- Timothy J Mcmahon4 shared
- Laura M. De Castro2 shared
- Allison E Ashley-Koch1 shared
Most similar at Duke University
Same institution · by research overlap
- Russell E Ware$48,672,245
- Hrishikesh Chakraborty$16,373,642
- Gayane Yenokyan$3,553,064
- Kanecia Obie Zimmerman$7,696,546
- Kevin A Schulman$2,895,275
Others in their field
Top investigators on “Sickle Cell Anemia”
- Russell E Ware · Duke University$48,435,687
- Michael Rutledge Debaun · Vanderbilt University Medical Center$38,268,866
- Martin H. Steinberg · Boston Medical Center$25,628,557
- Michael L. Terrin · Clinical Trials And Surveys Corporation$23,855,067
- Barbara L Kroner · Research Triangle Institute$21,141,016
- Garret A Fitzgerald · University Of Pennsylvania$20,602,198
Research focus
Sickle Cell AnemiaTransfusionErythrocytesClinical ResearchPatient Oriented ResearchResearch PersonnelHematologyAreaMedicineResponseProgramsClinical TrialsSickle CellLeadGenetic PolymorphismPathologic ProcessNorth CarolinaLamininGeneticFunctional DisorderNci Scholars ProgramDesignBaseBasic Science
Grant awards (73)
'Omics predictors of Sickle Cell Severity and Survival$430,956
R21 · FY2024 · AG
A Phase II trial of topical sodium nitrite in patients with sickle cell disease and leg ulcers$469,877
R01 · FY2021 · FD · contact PI
Transfusion Medicine and Hematology$549,038
T32 · FY2018 · HL · contact PI
Transfusion Medicine and Hematology$537,088
T32 · FY2017 · HL · contact PI
Transfusion Medicine and Hematology$5,607
T32 · FY2017 · HL · contact PI
Transfusion Medicine and Hematology$528,962
T32 · FY2016 · HL · contact PI
Duke - UNC Clinical Hematology and Transfusion Research Career Development Progra$438,575
K12 · FY2016 · HL · contact PI
Factor XIII and Fibrinogen: Mechanisms of Genetic Risk in SCD-Related Priapism$195,250
R21 · FY2016 · DK · contact PI
Duke - UNC Clinical Hematology and Transfusion Research Career Development Progra$388,774
K12 · FY2015 · HL · contact PI
Role of RBC NO and ATP in Sickle Vasculopathy$386,612
R01 · FY2015 · HL · contact PI
TRANSFUSION MEDICINE AND HEMATOLOGY$350,576
T32 · FY2015 · HL · contact PI
Factor XIII and Fibrinogen: Mechanisms of Genetic Risk in SCD-Related Priapism$249,750
R21 · FY2015 · DK · contact PI
TRANSFUSION MEDICINE AND HEMATOLOGY$503,662
T32 · FY2014 · HL · contact PI
Duke - UNC Clinical Hematology and Transfusion Research Career Development Progra$389,467
K12 · FY2014 · HL · contact PI
Role of RBC NO and ATP in Sickle Vasculopathy$384,650
R01 · FY2014 · HL · contact PI
TRANSFUSION MEDICINE AND HEMATOLOGY$496,288
T32 · FY2013 · HL · contact PI
Duke - UNC Clinical Hematology and Transfusion Research Career Development Progra$390,169
K12 · FY2013 · HL · contact PI
Role of RBC NO and ATP in Sickle Vasculopathy$373,660
R01 · FY2013 · HL · contact PI
TRANSFUSION MEDICINE AND HEMATOLOGY$496,288
T32 · FY2012 · HL · contact PI
Duke - UNC Clinical Hematology and Transfusion Research Career Development Progra$392,590
K12 · FY2012 · HL · contact PI
Role of RBC NO and ATP in Sickle Vasculopathy$392,500
R01 · FY2012 · HL · contact PI
TRANSFUSION MEDICINE AND HEMATOLOGY$473,924
T32 · FY2011 · HL · contact PI
PROPRANOLOL AS ANTI-ADHESIVE THERAPY IN SCD$223,681
R21 · FY2011 · HL · contact PI
Duke-UNC Clinical Hematology Research Career Development Program$393,496
K12 · FY2010 · HL · contact PI
Transfusion Medicine and Related Areas$285,864
T32 · FY2010 · HL · contact PI
PROPRANOLOL AS ANTI-ADHESIVE THERAPY IN SCD$192,550
R21 · FY2010 · HL · contact PI
Duke/UNC Comprehensive Sickle Cell Center$57,672
U54 · FY2010 · HL · contact PI
Duke-UNC Clinical Hematology Research Career Development Program$395,434
K12 · FY2009 · HL · contact PI
Transfusion Medicine and Related Areas$380,668
T32 · FY2009 · HL · contact PI
Duke/UNC Comprehensive Sickle Cell Center$127,842
U54 · FY2009 · HL · contact PI
Pulmonary Hypertension in SCD$1,499,907
R01 · FY2008 · HL · contact PI
Duke-UNC Clinical Hematology Research Career Development Program$396,837
K12 · FY2008 · HL · contact PI
Transfusion Medicine and Related Areas$377,506
T32 · FY2008 · HL · contact PI
Duke/UNC Comprehensive Sickle Cell Center$1,813,090
U54 · FY2007 · HL · contact PI
Pulmonary Hypertension in SCD$1,602,077
R01 · FY2007 · HL · contact PI
Duke-UNC Clinical Hematology Research Career Development Program$398,198
K12 · FY2007 · HL · contact PI
Transfusion Medicine and Related Areas$377,506
T32 · FY2007 · HL · contact PI
Duke-UNC Sickle Cell Disease Clinical Research Network$149,721
U10 · FY2007 · HL · contact PI
Duke/UNC Comprehensive Sickle Cell Center$83,651
U54 · FY2007 · HL · contact PI
Pulmonary Hypertension in SCD$1,642,787
R01 · FY2006 · HL · contact PI
Duke/UNC Comprehensive Sickle Cell Center$1,557,333
U54 · FY2006 · HL · contact PI
Duke-UNC Clinical Hematology Research Career Development Program$401,520
K12 · FY2006 · HL · contact PI
Transfusion Medicine and Related Areas$381,598
T32 · FY2006 · HL · contact PI
Duke-UNC Sickle Cell Disease Clinical Research Network$153,748
U10 · FY2006 · HL · contact PI
Duke/UNC Comprehensive Sickle Cell Center$82,308
U54 · FY2006 · HL · contact PI
Pulmonary Hypertension in SCD$1,927,775
R01 · FY2005 · HL
Duke/UNC Comprehensive Sickle Cell Center$1,813,385
U54 · FY2005 · HL
Outcome Modifying Genes in Sickle Cell Disease$519,901
R01 · FY2005 · HL
TRANSFUSION MEDICINE AND RELATED AREAS$238,799
T32 · FY2005 · HL
Adrenergic Receptor Variants and RBC Adhesion in SCD$154,000
R21 · FY2005 · DK
Duke/UNC Comprehensive Sickle Cell Center$100,000
U54 · FY2005 · HL
OUTCOME MODIFYING GENES IN SICKLE CELL DISEASE$10,984
M01 · FY2005 · RR
Duke/UNC Comprehensive Sickle Cell Center$1,356,239
U54 · FY2004 · HL
Outcome Modifying Genes in Sickle Cell Disease$620,303
R01 · FY2004 · HL
Transfusion Medicine and Related Areas$298,777
T32 · FY2004 · HL
Adrenergic Receptor Variants and RBC Adhesion in SCD$150,760
R21 · FY2004 · DK
Outcome Modifying Genes in Sickle Cell Disease$46,200
R01 · FY2004 · HL
Outcome Modifying Genes in Sickle Cell Disease$18,183
M01 · FY2004 · RR
Duke/UNC Comprehensive Sickle Cell Center$1,367,633
U54 · FY2003 · HL
Outcome Modifying Genes in Sickle Cell Disease$879,236
R01 · FY2003 · HL
TRANSFUSION MEDICINE AND RELATED AREAS$302,362
T32 · FY2003 · HL
Outcome Modifying Genes in Sickle Cell Disease$46,200
R01 · FY2003 · HL
Outcome Modifying Genes in Sickle Cell Disease$777,321
R01 · FY2002 · HL
FACTORS INVOLVED IN B-CAM/LU MEDIATED ADHESION$392,407
R01 · FY2002 · HL
TRANSFUSION MEDICINE AND RELATED AREAS$298,650
T32 · FY2002 · HL
Outcome Modifying Genes in Sickle Cell Disease$8,800
R01 · FY2002 · HL
Outcome Modifying Genes in Sickle Cell Disease$727,307
R01 · FY2001 · HL
TRANSFUSION MEDICINE AND RELATED AREAS$275,849
T32 · FY2001 · HL
FACTORS INVOLVED IN B-CAM/LU MEDIATED ADHESION$255,943
R01 · FY2001 · HL
FACTORS INVOLVED IN B-CAM/LU MEDIATED ADHESION$129,659
R01 · FY2001 · HL
SICKLE CELL ADHESION$337,999
R01 · FY2000 · HL
FACTORS INVOLVED IN B-CAM/LU MEDIATED ADHESION$250,540
R01 · FY2000 · HL
TRANSFUSION MEDICINE AND RELATED AREAS$162,097
T32 · FY2000 · HL